Clinical review: Sepsis and septic shock - the potential of gene arrays

Critical Care

Volumn 16, Issue 1, 2012, Pages

  Wong, Hector R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; COMPLEMENTARY DNA; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; NEUTROPHIL COLLAGENASE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; ZINC; ZINC TRANSPORTER;

ADAPTIVE IMMUNITY; DISEASE SEVERITY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; RNA TRANSCRIPTION; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; STANDARDIZATION; VENTILATOR ASSOCIATED PNEUMONIA; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETICS; METHODOLOGY;

GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEPSIS; SHOCK, SEPTIC;

EID: 84856707802     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10537     Document Type: Review

References (71)

1. Christie JD. Microarrays. Crit Care Med 2005, 33(12 Suppl):S449-452.
2. Gershon D. Microarray technology: an array of opportunities. Nature 2002, 416:885-891. 10.1038/416885a, 11976691.
3. Tang BM, Huang SJ, McLean AS. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 2010, 14:R237. 10.1186/cc9392, 3219990, 21190579.
4. Malone JH, Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol 2011, 9:34. 10.1186/1741-7007-9-34, 3104486, 21627854.
5. Kim K, Zakharkin SO, Allison DB. Expectations, validity, and reality in gene expression profiling. J Clin Epidemiol 2010, 63:950-959. 10.1016/j.jclinepi.2010.02.018, 2910173, 20579843.
6. Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet 2011, 12:87-98. 10.1038/nrg2934, 3031867, 21191423.
7. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14:2534-2543. 10.1097/01.ASN.0000088027.54400.C6, 14514731.
8. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006, 7:55-65. 10.1038/nrg1749, 16369572.
9. Cvijanovich N, Shanley TP, Lin R, Allen GL, Thomas NJ, Checchia P, Anas N, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Wong HR, . Genomics of Pediatric SIRS/Septic Shock Investigators Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008, 34:127-134. 10.1152/physiolgenomics.00025.2008, 2440641, 18460642, Genomics of Pediatric SIRS/Septic Shock Investigators.
10. Yang MC, Yang JJ, McIndoe RA, She JX. Microarray experimental design: power and sample size considerations. Physiol Genomics 2003, 16:24-28. 10.1152/physiolgenomics.00037.2003, 14532333.
11. Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, Freishtat RJ, Anas N, Meyer K, Checchia PA, Monaco M, Odom K, Shanley TP. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med 2009, 7:34. 10.1186/1741-7015-7-34, 2720987, 19624809.
12. Eichler GS, Huang S, Ingber DE. Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics 2003, 19:2321-2322. 10.1093/bioinformatics/btg307, 14630665.
13. Guo Y, Eichler GS, Feng Y, Ingber DE, Huang S. Towards a holistic, yet genecentered analysis of gene expression profiles: a case study of human lung cancers. J Biomed Biotechnol 2006, 2006:69141. 1698264, 17489018.
14. Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Shanley TP, Bigham MT, Wheeler DS, Doughty LA, Tegtmeyer K, Poynter SE, Kaplan JM, Chima RS, Stalets E, Basu RK, Varisco BM, Barr FE. Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 2011, 39:2511-2517. 10.1097/CCM.0b013e3182257675, 21705885.
15. Wong HR, Wheeler DS, Tegtmeyer K, Poynter SE, Kaplan JM, Chima RS, Stalets E, Basu RK, Doughty LA. Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med 2010, 38:1955-1961. 2943553, 20639748.
16. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF, . Inflamm and Host Response to Injury Large Scale Collab. Res. Program A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037. 10.1038/nature03985, 16136080, Inflamm and Host Response to Injury Large Scale Collab. Res. Program.
17. Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, Penfil S, Monaco M, Odoms K, Barnes M, Sakthivel B, Aronow BJ, Wong HR. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007, 13:495-508. 2014731, 17932561.
18. Boujoukos AJ, Martich GD, Supinski E, Suffredini AF. Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J Appl Physiol 1993, 74:3027-3033.
19. DeLa Cadena RA, Suffredini AF, Page JD, Pixley RA, Kaufman N, Parrillo JE, Colman RW. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 1993, 81:3313-3317.
20. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321:280-287. 10.1056/NEJM198908033210503, 2664516.
21. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989, 320:1165-1172. 10.1056/NEJM198905043201802, 2496309.
22. Talwar S, Munson PJ, Barb J, Fiuza C, Cintron AP, Logun C, Tropea M, Khan S, Reda D, Shelhamer JH, Danner RL, Suffredini AF. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 2006, 25:203-215. 10.1152/physiolgenomics.00192.2005, 16403844.
23. Prabhakar U, Conway TM, Murdock P, Mooney JL, Clark S, Hedge P, Bond BC, Jazwinska EC, Barnes MR, Tobin F, Damian-Iordachi V, Greller L, Hurle M, Stubbs AP, Li Z, Valoret EI, Erickson-Miller C, Cass L, Levitt B, Davis HM, Jorkasky DK, Williams WV. Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol 2005, 24:410-431. 10.1089/dna.2005.24.410, 16008510.
24. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 2007, 176:676-684. 10.1164/rccm.200612-1819OC, 17575094.
25. Lowry SF. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 2005, 24(Suppl 1):94-100.
26. Johnson SB, Lissauer M, Bochicchio GV, Moore R, Cross AS, Scalea TM. Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg 2007, 245:611-621. 10.1097/01.sla.0000251619.10648.32, 1877042, 17414611.
27. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006, 106:63-71. 10.1016/j.imlet.2006.04.010, 16765452.
28. Payen D, Lukaszewicz AC, Belikova I, Faivre V, Gelin C, Russwurm S, Launay JM, Sevenet N. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 2008, 34:1371-1376. 10.1007/s00134-008-1048-1, 18392609.
29. Prucha M, Ruryk A, Boriss H, Moller E, Zazula R, Herold I, Claus RA, Reinhart KA, Deigner P, Russwurm S. Expression profiling: toward an application in sepsis diagnostics. Shock 2004, 22:29-33. 10.1097/01.shk.0000129199.30965.02, 15201698.
30. Tang BM, McLean AS, Dawes IW, Huang SJ, Cowley MJ, Lin RC. Geneexpression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 2008, 36:1125-1128. 10.1097/CCM.0b013e3181692c0b, 18379237.
31. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009, 37:882-888. 10.1097/CCM.0b013e31819b52fd, 19237892.
32. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, Shanley TP, . Genomics of Pediatric SIRS/Septic Shock Investigators Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009, 37:1558-1566. 10.1097/CCM.0b013e31819fcc08, 2747356, 19325468, Genomics of Pediatric SIRS/Septic Shock Investigators.
33. Wong HR, Freishtat RJ, Monaco M, Odoms K, Shanley TP. Leukocyte subsetderived genomewide expression profiles in pediatric septic shock. Pediatr Crit Care Med 2010, 11:349-355. 2927840, 20009785.
34. Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, Penfil S, Monaco M, Tagavilla MA, Odoms K, Dunsmore K, Barnes M, Aronow BJ, . Genomics of Pediatric SIRS/Septic Shock Investigators Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007, 30:146-155. 10.1152/physiolgenomics.00024.2007, 2770262, 17374846, Genomics of Pediatric SIRS/Septic Shock Investigators.
35. Carlet J, Cohen J, Calandra T, Opal SM, Masur H. Sepsis: time to reconsider the concept. Crit Care Med 2008, 36:964-966. 10.1097/CCM.0B013E318165B886, 18431286.
36. Marshall JC. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2003, 2:391-405. 10.1038/nrd1084, 12750742.
37. Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, Fisher CJ, Faist E, Reinhart K. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003, 31:1560-1567. 10.1097/01.CCM.0000065186.67848.3A, 12771633.
38. Russell JA. Gene expression in human sepsis: what have we learned?. Crit Care 2011, 15:121.
39. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000, 181:176-180. 10.1086/315214, 10608764.
40. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006, 177:1967-1974.
41. Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG. Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol 2007, 179:623-630.
42. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
43. Hotchkiss RS, Opal S. Immunotherapy for sepsis - a new approach against an ancient foe. N Engl J Med 2010, 363:87-89. 10.1056/NEJMcibr1004371, 20592301.
44. Unsinger J, McGlynn M, Kasten KR, Hoekzema AS, Watanabe E, Muenzer JT, McDonough JS, Tschoep J, Ferguson TA, McDunn JE, Morre M, Hildeman DA, Caldwell CC, Hotchkiss RS. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010, 184:3768-3779. 10.4049/jimmunol.0903151, 2914630, 20200277.
45. Kasten KR, Prakash PS, Unsinger J, Goetzman HS, England LG, Cave CM, Seitz AP, Mazuski CN, Zhou TT, Morre M, Hotchkiss RS, Hildeman DA, Caldwell CC. Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun 2010, 78:4714-4722. 10.1128/IAI.00456-10, 2976361, 20823197.
46. Wynn JL, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Shanley TP, Bigham MT, Banschbach S, Beckman E, Wong HR. The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med 2011, [Epub ahead of print].
47. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107. 10.1038/35074114, 11323674.
48. Lissauer ME, Johnson SB, Bochicchio GV, Feild CJ, Cross AS, Hasday JD, Whiteford CC, Nussbaumer WA, Towns M, Scalea TM. Differential expression of toll-like receptor genes: sepsis compared with sterile inflammation 1 day before sepsis diagnosis. Shock 2009, 31:238-244. 10.1097/SHK.0b013e3181834991, 18665047.
49. Cobb JP, Moore EE, Hayden DL, Minei JP, Cuschieri J, Yang J, Li Q, Lin N, Brownstein BH, Hennessy L, Mason PH, Schierding WS, Dixon DJ, Tompkins RG, Warren HS, Schoenfeld DA, Maier RV. Validation of the riboleukogram to detect ventilator-associated pneumonia after severe injury. Ann Surg 2009, 250:531-539. 3047595, 19730236.
50. McDunn JE, Husain KD, Polpitiya AD, Burykin A, Ruan J, Li Q, Schierding W, Lin N, Dixon D, Zhang W, Coopersmith CM, Dunne WM, Colonna M, Ghosh BK, Cobb JP. Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram. PLoS One 2008, 3:e1564. 10.1371/journal.pone.0001564, 2215774, 18270561.
51. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, Wittkowski KM, Piqueras B, Banchereau J, Palucka AK, Chaussabel D. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007, 109:2066-2077. 10.1182/blood-2006-02-002477, 1801073, 17105821.
52. Pachot A, Cazalis MA, Venet F, Turrel F, Faudot C, Voirin N, Diasparra J, Bourgoin N, Poitevin F, Mougin B, Lepape A, Monneret G. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol 2008, 180:6421-6429.
53. Nowak JE, Wheeler DS, Harmon KK, Wong HR. Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock. Pediatr Crit Care Med 2010, 11:213-216. 10.1097/PCC.0b013e3181b8076c, 2837132, 19794326.
54. Wong HR, Cvijanovich N, Wheeler DS, Bigham MT, Monaco M, Odoms K, Macias WL, Williams MD. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008, 178:276-282. 10.1164/rccm.200801-131OC, 2542425, 18511707.
55. Calfee CS, Thompson BT, Parsons PE, Ware LB, Matthay MA, Wong HR. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Crit Care Med 2010, 38:1436-1441. 10.1097/CCM.0b013e3181de42ad, 20386309.
56. Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med 2011, 12:165-173. 10.1097/PCC.0b013e3181e28876, 20473243.
57. Standage SW, Wong HR. Biomarkers for pediatric s epsis and septic shock. Expert Rev Anti Infect Ther 2011, 9:71-79. 10.1586/eri.10.154, 3033193, 21171879.
58. Kotz KT, Xiao W, Miller-Graziano C, Qian WJ, Rus som A, Warner EA, Moldawer LL, De A, Bankey PE, Petritis BO, Camp DG 2, Rosenbach AE, Goverman J, Fagan SP, Brownstein BH, Irimia D, Xu W, Wilhelmy J, Mindrinos MN, Smith RD, Davis RW, Tompkins RG, Toner M, . Inflammation and the Host Response to Injury Collaborative Research Program Clinical microfluidics for neutrophil genomics and proteomics. Nat Med 2010, 16:1042-1047. 10.1038/nm.2205, 3136804, 20802500, Inflammation and the Host Response to Injury Collaborative Research Program.
59. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowid ar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, James JJ, Maysuria M, Mitton JD, Oliveri P, Osborn JL, Peng T, Ratcliffe AL, Webster PJ, Davidson EH, Hood L, Dimitrov K. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008, 26:317-325. 10.1038/nbt1385, 18278033.
60. Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, Oragui EE, McCabe C, Welch SB, Whitney A, O'Gara P, Nadel S, Relman DA, Harding SE, Levin M. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004, 363:203-209. 10.1016/S0140-6736(03)15326-3, 14738793.
61. Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol 2007, 28:1-4. 10.1016/j.it.2006.11.005, 17126599.
62. Cvijanovich NZ, King JC, Flori HR, Gildengorin G, Wong HR. Zinc homeostasis in pediatric critical illness. Pediatr Crit Care Med 2009, 10:29-34. 10.1097/PCC.0b013e31819371ce, 19057435.
63. Heyland DK, Jones N, Cvijanovich NZ, Wong H. Zinc supplementation in critically ill patients: a key pharmaconutrient?. JPEN J Parenter Enteral Nutr 2008, 32:509-519. 10.1177/0148607108322402, 18669902.
64. Weitzel LR, Mayles WJ, Sandoval PA, Wischmeyer PE. Effects of pharmaconutrients on cellular dysfunction and the microcirculation in critical illness. Curr Opin Anaesthesiol 2009, 22:177-183. 10.1097/ACO.0b013e328328d32f, 19307892.
65. Bao S, Liu MJ, Lee B, Besecker B, Lai JP, Guttridge DC, Knoell DL. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2010, 298:L744-754. 10.1152/ajplung.00368.2009, 2886607, 20207754.
66. Knoell DL, Julian MW, Bao S, Besecker B, Macre J E, Leikauf GD, DiSilvestro RA, Crouser ED. Zinc deficiency increases organ damage and mortality in a murine model of polymicrobial sepsis. Crit Care Med 2009, 37:1380-1388. 10.1097/CCM.0b013e31819cefe4, 2905048, 19242332.
67. Besecker BY, Exline MC, Hollyfield J, Phillips G, Disilvestro RA, Wewers MD, Knoell DL. A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am J Clin Nutr 2011, 93:1356-1364. 10.3945/ajcn.110.008417, 21525204.
68. Knoell DL, Liu MJ. Impact of zinc metabolism on innate immune function in the setting of sepsis. Int J Vitam Nutr Res 2010, 80:271-277.
69. Solan PD, Dunsmore KE, Denenberg AG, Odom K, Zingarelli B, Wong HR. A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med 2012, 40:379-387.
70. Van Lint P, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev 2006, 17:217-223. 10.1016/j.cytogfr.2006.04.001, 16820317.
71. Vanlaere I, Libert C. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 2009, 22:224-239. 10.1128/CMR.00047-08, 2668236, 19366913.